A Study to Evaluate ALN-6222 in Participants With Obesity | MicrobiomeTrials← Back to trialsNCT07624071
A Study to Evaluate ALN-6222 in Participants With Obesity
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-06-04Est. Completion: 2027-12-14
Enrollment target: 88 participants Locations- Clinical Trial Site, Mount Royal, Canada
Other microbiome trials you might be interested in
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disease, often compounded by obesity, that leads to serious l…
Multiple LocationsEst. completion Jan 12, 2027
Obesity
A 12-month randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 6-month weight loss perio…
Chicago, United StatesCompleted Feb 1, 2025
Type 2 Diabetes Mellitus (T2DM)
Obesity (Disorder)
Overweight
Metabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, KazakhstanEst. completion Nov 2026